Insider Trading activities of Seattle Genetics Inc /wa insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seattle Genetics Inc /wa since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seattle Genetics Inc /wa since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Seattle Genetics Inc /wa since 2005. The reporting company's ticker symbol is SGEN. The reporting company's CIK number is 1060736.
The total value of stock buying since 2005 is $1,202,514,629.
The total value of stock sales since 2005 is $248,686,406.
The total value of stock option exercises since 2005 is $46,022,989.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Seattle Genetics Inc /wa insiders (SGEN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-11-18 Baker Brothers Life Sciences Lp (Director) Buy 14,638 43.42 635,552
2015-11-17 Siegall Clay B (President and CEO) Sale 87,473 45.40 3,970,924
2015-11-11 Cline Darren S (SVP, Commercial) Sale 5,769 45.68 263,545
2015-11-10 Baker Brothers Life Sciences Lp (Director) Buy 9,400 44.00 413,600
2015-11-09 Baker Brothers Life Sciences Lp (Director) Buy 507,300 43.57 22,102,553
2015-11-06 Baker Brothers Life Sciences Lp (Director) Buy 417,924 41.91 17,514,776
2015-11-06 Dobmeier Eric (Chief Operating Officer) Sale 17,452 42.50 741,710
2015-11-05 Gryska David W (Director) Sale 10,000 43.57 435,740
2015-11-04 Siegall Clay B (President and CEO) Sale 3,718 43.14 160,394
2015-11-04 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-10-28 Siegall Clay B (President and CEO) Option Ex 32,265 5.04 162,615
2015-10-05 Siegall Clay B (President and CEO) Sale 3,718 41.30 153,542
2015-10-05 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-09-29 Simpson Todd E (Chief Financial Officer) Option Ex 14,801 13.73 203,217
2015-09-15 Baker Brothers Life Sciences Lp (Director) Buy 626,259 47.64 29,837,483
2015-09-14 Baker Brothers Life Sciences Lp (Director) Buy 320,438 45.76 14,663,883
2015-09-11 Baker Brothers Life Sciences Lp (Director) Buy 4,212,787 42.49 179,009,745
2015-09-03 Siegall Clay B (President and CEO) Sale 3,718 40.12 149,166
2015-09-03 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-08-24 Dobmeier Eric (Chief Operating Officer) Option Ex 9,866 17.99 177,488
2015-08-20 Cline Darren S (SVP, Commercial) Sale 4,462 42.02 187,514
2015-08-20 Drachman Jonathan G (CMO & EVP, R & D) Sale 4,462 42.02 187,511
2015-08-20 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Sale 5,997 42.02 252,023
2015-08-20 Simpson Todd E (Chief Financial Officer) Sale 5,825 42.02 244,795
2015-08-20 Dobmeier Eric (Chief Operating Officer) Sale 17,096 42.02 718,458
2015-08-20 Siegall Clay B (President and CEO) Sale 31,754 42.02 1,334,430
2015-08-05 Siegall Clay B (President and CEO) Sale 3,718 46.91 174,411
2015-08-05 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-07-06 Siegall Clay B (President and CEO) Sale 3,718 46.94 174,515
2015-07-06 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-06-03 Siegall Clay B (President and CEO) Sale 3,718 45.72 169,972
2015-06-03 Siegall Clay B (President and CEO) Option Ex 3,718 5.63 20,932
2015-05-21 Baker Brothers Life Sciences Lp (Director) Buy 362,459 43.46 15,753,555
2015-05-20 Baker Brothers Life Sciences Lp (Director) Buy 374,298 42.07 15,745,219
2015-05-19 Baker Brothers Life Sciences Lp (Director) Buy 214,129 40.91 8,759,375
2015-05-11 Baker Brothers Life Sciences Lp (Director) Option Ex 20,000 5.11 102,200
2015-05-08 Dobmeier Eric (Chief Operating Officer) Sale 17,074 40.38 689,379
2015-05-08 Siegall Clay B (President and CEO) Sale 52,052 40.65 2,116,069
2015-05-08 Siegall Clay B (President and CEO) Option Ex 52,052 5.63 293,052
2015-05-07 Baker Brothers Life Sciences Lp (Director) Buy 47,717 37.11 1,770,873
2015-05-06 Baker Brothers Life Sciences Lp (Director) Buy 453,995 36.22 16,441,882
2015-05-05 Baker Brothers Life Sciences Lp (Director) Buy 530,952 34.49 18,312,003
2015-04-08 Gryska David W (Director) Option Ex 5,000 8.38 41,900
2015-03-13 Cline Darren S (SVP, Commercial) Sale 7,500 38.65 289,875
2015-03-12 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Sale 20,000 36.65 733,000
2015-03-12 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Option Ex 20,000 9.23 184,600
2015-03-10 Baker Brothers Life Sciences Lp (Director) Buy 9,319 34.59 322,362
2015-03-09 Baker Brothers Life Sciences Lp (Director) Buy 275,717 34.66 9,555,248
2015-03-04 Baker Brothers Life Sciences Lp (Director) Buy 23,621 34.81 822,152
2015-03-03 Baker Brothers Life Sciences Lp (Director) Buy 425,220 34.84 14,815,090
2015-02-25 Baker Brothers Life Sciences Lp (Director) Buy 63,650 35.03 2,229,595
2015-02-24 Baker Brothers Life Sciences Lp (Director) Buy 217,465 33.68 7,324,656
2015-01-06 Siegall Clay B (President and CEO) Sale 16,804 31.80 534,316
2015-01-06 Siegall Clay B (President and CEO) Option Ex 16,804 5.92 99,479
2014-12-16 Baker Brothers Life Sciences Lp (Director) Buy 1,909,979 31.63 60,418,365
2014-12-15 Baker Brothers Life Sciences Lp (Director) Buy 973,399 31.62 30,774,982
2014-12-10 14159, L.p. (Director) Buy 654,150 34.52 22,582,566
2014-12-09 14159, L.p. (Director) Buy 128,430 33.94 4,359,042
2014-12-08 14159, L.p. (Director) Buy 465,316 32.98 15,347,517
2014-11-12 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 10,000 37.52 375,170
2014-11-12 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Option Ex 10,000 9.23 92,300
2014-11-10 14159, L.p. (Director) Buy 241,249 36.49 8,802,211
2014-11-07 14159, L.p. (Director) Buy 211,704 35.53 7,522,266
2014-11-06 14159, L.p. (Director) Buy 1,200,972 34.26 41,150,104
2014-09-04 Siegall Clay B (President and CEO) Sale 5,600 42.54 238,224
2014-09-04 Siegall Clay B (President and CEO) Option Ex 5,600 5.92 33,152
2014-08-27 Dobmeier Eric (Chief Operating Officer) Option Ex 8,333 12.00 99,996
2014-08-25 Dobmeier Eric (Chief Operating Officer) Sale 4,818 43.55 209,819
2014-08-24 Drachman Jonathan G (CMO & EVP, R & D) Sale 2,772 43.55 120,717
2014-08-24 Boerner Christopher S. (Executive Vice President, Comm) Sale 1,248 43.55 54,349
2014-08-24 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 3,310 43.55 144,147
2014-08-24 Simpson Todd E (Chief Financial Officer) Sale 3,696 43.55 160,957
2014-08-24 Siegall Clay B (President and CEO) Sale 25,507 43.55 1,110,804
2014-08-12 Siegall Clay B (President and CEO) Sale 8,500 40.48 344,088
2014-08-12 Siegall Clay B (President and CEO) Option Ex 8,500 5.92 50,320
2014-08-11 Siegall Clay B (President and CEO) Sale 2,700 40.05 108,129
2014-08-11 Siegall Clay B (President and CEO) Option Ex 2,700 5.92 15,984
2014-06-13 14159, L.p. (Director) Buy 88,587 39.87 3,531,520
2014-06-12 14159, L.p. (Director) Buy 128,008 39.92 5,109,823
2014-06-10 Siegall Clay B (President and CEO) Sale 11,200 40.14 449,579
2014-06-10 Siegall Clay B (President and CEO) Option Ex 11,200 5.92 66,304
2014-06-09 14159, L.p. (Director) Buy 251,093 38.76 9,731,862
2014-06-06 14159, L.p. (Director) Buy 174,987 37.46 6,554,488
2014-06-05 14159, L.p. (Director) Buy 120,172 37.65 4,524,836
2014-06-04 14159, L.p. (Director) Buy 87,042 36.22 3,152,226
2014-06-03 14159, L.p. (Director) Buy 100,304 34.92 3,503,016
2014-06-02 14159, L.p. (Director) Buy 94,617 34.13 3,229,562
2014-05-16 14159, L.p. (Director) Buy 168,411 34.06 5,736,078
2014-05-15 14159, L.p. (Director) Buy 21,200 34.18 724,658
2014-05-14 14159, L.p. (Director) Option Ex 30,000 7.26 217,800
2014-05-09 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 10,000 35.00 350,000
2014-05-09 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Option Ex 10,000 9.23 92,300
2014-04-03 Siegall Clay B (President and CEO) Sale 5,600 43.34 242,704
2014-04-03 Siegall Clay B (President and CEO) Option Ex 5,600 5.92 33,152
2014-03-05 Siegall Clay B (President and CEO) Sale 9,318 52.89 492,801
2014-03-05 Siegall Clay B (President and CEO) Option Ex 9,318 5.78 53,811
2014-02-28 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Option Ex 11,300 9.23 104,299
2014-02-21 Boerner Christopher S. (SVP, Commercial) Sale 1,452 54.98 79,825
2014-02-21 Berger Franklin M (Director) Option Ex 7,500 12.76 95,700
2014-02-20 Drachman Jonathan G (CMO & EVP, R & D) Sale 1,241 53.25 66,083
2014-02-19 Himes Vaughn B (EVP, Tech, Ops. & Proc. Sci.) Sale 5,088 52.01 264,626
2014-02-19 Himes Vaughn B (EVP, Tech, Ops. & Proc. Sci.) Option Ex 3,000 9.23 27,690
2014-02-18 Siegall Clay B (President and CEO) Sale 100,000 51.97 5,197,000
2014-02-13 Siegall Clay B (President and CEO) Option Ex 12,142 10.33 125,426
2014-01-21 Dobmeier Eric (Chief Operating Officer) Sale 56,010 47.93 2,684,447
2014-01-16 Drachman Jonathan G (CMO & EVP, R & D) Sale 1,201 45.75 54,945
2014-01-02 Siegall Clay B (President and CEO) Sale 1,858 39.27 72,956
2014-01-02 Siegall Clay B (President and CEO) Option Ex 1,858 10.33 19,193
2013-12-16 14159, L.p. (Director) Buy 78,759 39.92 3,143,823
2013-12-13 14159, L.p. (Director) Buy 43,709 39.66 1,733,280
2013-12-12 14159, L.p. (Director) Buy 284,610 39.59 11,267,140
2013-12-05 14159, L.p. (Director) Buy 365,676 44.01 16,092,303
2013-12-05 Siegall Clay B (President and CEO) Option Ex 18,996 5.92 112,456
2013-12-04 14159, L.p. (Director) Buy 270,795 43.23 11,705,926
2013-12-03 14159, L.p. (Director) Buy 369,430 42.43 15,673,806
2013-12-02 Siegall Clay B (President and CEO) Sale 2,000 41.25 82,492
2013-12-02 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-11-01 Siegall Clay B (President and CEO) Sale 2,000 38.63 77,254
2013-11-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-10-01 Siegall Clay B (President and CEO) Sale 2,000 43.87 87,732
2013-10-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-09-10 Dobmeier Eric (Chief Operating Officer) Sale 42,000 46.41 1,949,388
2013-09-10 Dobmeier Eric (Chief Operating Officer) Option Ex 40,000 20.69 827,720
2013-09-05 Dobmeier Eric (Chief Operating Officer) Sale 15,000 44.00 660,000
2013-09-05 Dobmeier Eric (Chief Operating Officer) Option Ex 15,000 15.46 231,900
2013-09-03 Dobmeier Eric (Chief Operating Officer) Sale 60,000 42.29 2,537,640
2013-09-03 Dobmeier Eric (Chief Operating Officer) Option Ex 68,223 12.95 883,146
2013-09-03 Gryska David W (Director) Sale 10,000 42.48 424,799
2013-09-03 Gryska David W (Director) Option Ex 10,000 10.08 100,800
2013-09-03 Siegall Clay B (President and CEO) Sale 102,000 43.34 4,421,088
2013-09-03 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-08-28 Berger Franklin M (Director) Option Ex 10,000 12.76 127,600
2013-08-28 Simpson Todd E (Chief Financial Officer) Option Ex 30,366 11.18 339,491
2013-08-27 Simpson Todd E (Chief Financial Officer) Sale 37,763 41.45 1,565,200
2013-08-27 Simpson Todd E (Chief Financial Officer) Option Ex 37,763 18.36 693,479
2013-08-19 Boerner Christopher S. (SVP, Commercial) Sale 226 40.91 9,245
2013-08-19 Himes Vaughn B (EVP, Tech. Ops. & Proc. Sci.) Sale 1,736 40.91 71,019
2013-08-19 Simpson Todd E (Chief Financial Officer) Sale 3,328 40.91 136,148
2013-08-19 Dobmeier Eric (Chief Operating Officer) Sale 3,328 40.91 136,148
2013-08-19 Siegall Clay B (President and CEO) Sale 7,653 40.91 313,084
2013-08-01 Siegall Clay B (President and CEO) Sale 2,000 40.03 80,064
2013-08-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-07-12 Simpson Todd E (Chief Financial Officer) Sale 47,527 37.94 1,803,174
2013-07-12 Simpson Todd E (Chief Financial Officer) Option Ex 47,527 13.73 652,545
2013-07-11 Simpson Todd E (Chief Financial Officer) Sale 45,000 36.94 1,662,300
2013-07-11 Simpson Todd E (Chief Financial Officer) Option Ex 45,000 12.08 543,600
2013-07-01 Siegall Clay B (President and CEO) Sale 2,000 32.59 65,186
2013-07-01 Siegall Clay B (President and CEO) Option Ex 2,000 10.33 20,660
2013-06-14 Akkaraju Srinivas (Director) Sale 5,000 32.75 163,750
2013-06-14 Akkaraju Srinivas (Director) Option Ex 5,000 8.38 41,900
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seattle Genetics Inc /wa (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.